Literature DB >> 2827074

Quantitative autoradiography of hippocampal GABAB and GABAA receptor changes in Alzheimer's disease.

D C Chu1, J B Penney, A B Young.   

Abstract

GABAB and GABAA receptors were examined by quantitative [3H]GABA autoradiography in postmortem human hippocampus from 6 histopathologically verified cases of dementia of the Alzheimer type (DAT) and 6 normal controls. Significant decrements in the Bmax for both types of GABA receptors were observed in DAT hippocampus as compared to normal controls. No significant differences in Kd values were revealed. As compared to controls, DAT hippocampus exhibited fewer GABAB receptors in stratum moleculare of the dentate gyrus, stratum lacunosum-moleculare and stratum pyramidale of CA1. Significant loss of GABAA receptors in DAT hippocampus was also observed in the CA1 pyramidal cell region. These changes could not be correlated with differences in age nor in postmortem delay between the two groups. These findings may reflect the neuronal pathologies in CA1 region, in dentate gyrus, and in projections from the entorhinal cortex which are associated with the memory impairment in DAT.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2827074     DOI: 10.1016/0304-3940(87)90264-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  14 in total

1.  GABA(B) receptor autoradiography in hippocampal sclerosis associated with human temporal lobe epilepsy.

Authors:  A Billinton; V H Baird; M Thom; J S Duncan; N Upton; N G Bowery
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

Review 2.  Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer's disease.

Authors:  Riqiang Yan; Qingyuan Fan; John Zhou; Robert Vassar
Journal:  Neurosci Biobehav Rev       Date:  2016-04-01       Impact factor: 8.989

3.  Excitatory amino acid binding sites in the hippocampal region of Alzheimer's disease and other dementias.

Authors:  J B Penney; W F Maragos; J T Greenamyre; D L Debowey; Z Hollingsworth; A B Young
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-04       Impact factor: 10.154

Review 4.  Implications for treatment: GABAA receptors in aging, Down syndrome and Alzheimer's disease.

Authors:  Robert A Rissman; William C Mobley
Journal:  J Neurochem       Date:  2011-03-28       Impact factor: 5.372

Review 5.  Opioid system and Alzheimer's disease.

Authors:  Zhiyou Cai; Anna Ratka
Journal:  Neuromolecular Med       Date:  2012-04-22       Impact factor: 3.843

6.  Influence of hippocampal GABAB receptor inhibition on memory in rats with acute β-amyloid toxicity.

Authors:  Azam Almasi; Mohammad Zarei; Safoura Raoufi; Abdolrahman Sarihi; Iraj Salehi; Alireza Komaki; Nasrin Hashemi-Firouzi; Siamak Shahidi
Journal:  Metab Brain Dis       Date:  2018-07-23       Impact factor: 3.584

7.  Studies of GABA(B) receptors labelled with [(3)H]-CGP62349 in hippocampus resected from patients with temporal lobe epilepsy.

Authors:  A P Princivalle; J S Duncan; M Thom; N G Bowery
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

8.  Microtransplantation of functional receptors and channels from the Alzheimer's brain to frog oocytes.

Authors:  R Miledi; Z Dueñas; A Martinez-Torres; C H Kawas; F Eusebi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-28       Impact factor: 11.205

9.  GABAB Receptors in Neurodegeneration.

Authors:  Alessandra P Princivalle
Journal:  Curr Top Behav Neurosci       Date:  2022

10.  Reversible GABAergic dysfunction involved in hippocampal hyperactivity predicts early-stage Alzheimer disease in a mouse model.

Authors:  Yang Li; Ke Zhu; Ning Li; Xiaotong Wang; Xuansheng Xiao; Linying Li; Lijuan Li; Ying He; Jinglan Zhang; Jiaoyang Wo; Yanqiu Cui; Haixia Huang; Jianliang Zhang; Wei Wang; Xiaomin Wang; Yan Zheng
Journal:  Alzheimers Res Ther       Date:  2021-06-14       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.